Maccabi: 0.01% infections so far after second Covid dose

Pfizer vaccination  / Photo: Company website
Pfizer vaccination / Photo: Company website

Early but encouraging data from Israel's Maccabi Health Services show 20 out of 128,600 who have received their second jab have been infected.

Maccabi Health Services reported this evening that less than 0.01% of its members who have received their second doses from the health maintenance organization (HMO) have been diagnosed with Covid-19.

The data from Maccabi Health Services digital health services division found that only 20 out of 128,600 people who received their second dose of the vaccination more than a week ago have been infected with Covid-19 to date. Maccabi stresses that this is only very preliminary data but nevertheless very encouraging data.

Maccabi reported that most of the 20 people who have been infected, despite having two doses of the vaccine, are over 55. Half of them have underlying conditions and half have none but all are experiencing mild symptoms such as headaches, coughing, weakness and tiredness. None of the 20 have been hospitalized are have even experienced a temperature above 38.5°C. Most of them were infected by another patient who had tested positive for the virus.

Maccabi said that it would continue to monitor the situation on a permanent basis and report its findings to the Ministry of Health. According to Pfizer, the vaccine was 95% effective in its trial, 28 days after the 43,000 participants in its trial received their second dose.

Maccabi Health Services quality, research and digital health services division head Dr. Anat Ekka Zohar said, "The fact that we are talking about people with different profiles, who have been infected, matches the reports from Pfizer's trial. Now it is important to track and to see, in accordance with our expectations, that whoever is infected despite the vaccination does not suffer from serious medical complications as a result of the virus."

Maccabi reports that it has so far inoculated 710,000 people including a second jab for 277,400 people.

Overall Israel's Ministry of Health reports that 2.64 million people have been vaccinated against Covid-19 in Israel including 1.2 million people who have received their second dose.

Published by Globes, Israel business news - en.globes.co.il - on January 25, 2021

© Copyright of Globes Publisher Itonut (1983) Ltd. 2021

Pfizer vaccination  / Photo: Company website
Pfizer vaccination / Photo: Company website
Jerusalem court cmplex credit: Zarhy Architects Tenders issued for two huge Jerusalem construction projects

The PFI tenders for the Gan Hotzvim tech campus and the courts complex include grants of NIS 1.7 billion for the winning bidders.

Israel Innovation Authority CEO Dror Bin Innovation Authority chief: Israel top for deep tech investment

Dror Bin told the Globes TECH IL conference that deep tech is the next wave for global tech and the rate of investment in Israel is the world's highest.

Gil Shwed and Nadav Zafrir credit: Menash Cohen With new CEO Check Point beats analysts in Q1

Revenue rose 6.5% and GAAP net profit rose 5% in Nadav Zafrir's first full quarter at the helm.

Nadav Zafrir credit: Niv Kantor Check Point CEO: We'll reinvent cybersecurity for the AI age

In his first interview since succeeding Gil Shwed, Nadav Zafrir was speaking at the Globes TECH IL Conference.

Tel Aviv light rail credit: Yossi Cohen Rishon Lezion to finance Red Line light rail extension

The Rishon Lezion Municipality will pay for part of the extension by marketing land above the planned underground depot.

Intel Haifa development center credit: Shutterstock Intel to cut 20% of workforce - report

"Bloomberg" reports that new CEO Lip-Bu Tan will announce the layoffs this week.

Healthee team credit: Healthee PR AI healthcare costs management co Healthee raises $50m

Healthee’s benefits and care navigation platform empowers employees and employers to make the most of their health benefits.

Former Shufersal CEO Itzik Abercohen credit: Eyal Izhar Competition Authority summons former Shufersal CEO to hearing

According to the indictment, Shufersal and Itzik Abercohen allegedly made public statements through which he attempted to reach arrangements to raise prices.

Reco founders Ofer Klein, Gal Nakash, and Tal Shapira credit: Elegant Photographics Israeli SaaS security co Reco raises $25m

The Tel Aviv-based company has developed a comprehensive application discovery engine capable of identifying and classifying over 50,000 applications, and providing visibility into an organization’s SaaS ecosystem.

Tel Aviv Stock Exchange credit: Tali Bogdanovsky TASE outperforms global markets in 2025

Boosted by the strong results of Israel's banks, the Tel Aviv Stock Exchange has demonstrated impressive resilience to domestic and foreign upheavals.

Metro credit: Bar Lavi Can Hyundai fill Metro vacuum created by China's exclusion?

The South Korean giant is reportedly eager to enter Israel's infrastructure sector but may not have the resources to dig the Metro tunnels.

Hero 120SF loitering munition  credit: Uvision Israeli firms to arm Germany with suicide drones

UVision's partnership with Rheinmetall and IAI's partnership with MBDA will help equip the German Army with an arsenal of loitering munitions.

Cipia Vision Credit: Company website Cipia Vision lays off 50% of workforce

The financially troubled Israeli auto-tech company raised NIS 68 million on the TASE in 2021 at a company valuation of NIS 354 million.

Israir aircraft credit: Moni Shafir Israir gets green light for Tel Aviv - New York flights

The US Department of Transport has approved US-Israel flights for the Israeli carrier.

Mentee Robotics founders credit: Mentee Robotics Shashua's Mentee to begin production of humanoid robots

Exclusive: Amnon's Shashua's Mentee Robotics will begin serial production next month of robots for use in logistics centers.

Elbit mobile mortar shell launching system credit: Elbit Systems US military aid changes hit small Israeli defense firms

The reduction to zero for overseas procurement from US military aid and the cancelation of reciprocal procurement will hurt defense companies, which unlike IAI, Elbit and Rafael, do not have US subsidiaries.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018